Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Site News
Market: Market:

Cocrystal Pharma Inc (COCP)

Cocrystal Pharma Inc (COCP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow Globe Newswire - Thu Dec 2, 7:00AM CST

BOTHELL, Wash., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that President and...

COCP : 0.7150 (-6.30%)
Cocrystal Pharma Presents Preclinical Data from COVID-19 Antiviral Programs and Outlines Near-Term Clinical Plans at the World Antiviral Congress 2021 Globe Newswire - Wed Dec 1, 3:05PM CST

Unveils designs for Phase 1 and 2 studies with intranasal/pulmonary and oral SARS-CoV-2 protease inhibitors; trial initiations expected in 2022 BOTHELL,...

COCP : 0.7150 (-6.30%)
Cocrystal Pharma, Inc. (COCP) Reports Q3 Loss, Lags Revenue Estimates Zacks - Mon Nov 15, 11:25AM CST

Cocrystal Pharma, Inc. (COCP) delivered earnings and revenue surprises of 0.00% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?...

COCP : 0.7150 (-6.30%)
Will Cocrystal Pharma, Inc. (COCP) Report Negative Q3 Earnings? What You Should Know Zacks - Mon Nov 8, 2:00PM CST

Cocrystal Pharma, Inc. (COCP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

COCP : 0.7150 (-6.30%)
Cocrystal Pharma’s SARS-CoV-2 Main Protease Inhibitors Demonstrate Pan-viral Activity against Human Common Coronaviruses, Noroviruses, Rhinoviruses, and Enteroviruses Globe Newswire - Mon Nov 8, 7:00AM CST

BOTHELL, Wash., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that its SARS-CoV-2 main...

COCP : 0.7150 (-6.30%)
Cocrystal Pharma Submits Pre-Investigational New Drug Briefing Package to the FDA for Clinical Development Guidance of CDI-45205 for COVID-19 Treatment Globe Newswire - Mon Nov 1, 7:00AM CDT

FDA’s response is expected to provide greater clarity and guidance on designing Phase 1 and Phase 2 clinical trials for CDI-45205 BOTHELL, Wash., Nov....

COCP : 0.7150 (-6.30%)
Cocrystal Pharma to Present at the Dawson James 2021 Small Cap Growth Conference on October 21, 2021 Globe Newswire - Thu Oct 14, 7:00AM CDT

BOTHELL, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology...

COCP : 0.7150 (-6.30%)
Cocrystal Pharma Receives Australian Regulatory Clearance to Initiate Phase 1 Study of CC-42344 for the Treatment of Pandemic and Seasonal Influenza Globe Newswire - Wed Oct 6, 7:49AM CDT

BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology...

COCP : 0.7150 (-6.30%)
Cocrystal Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Globe NewsWire - Tue Sep 7, 7:00AM CDT

BOTHELL, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company, announces that management will...

COCP : 0.7150 (-6.30%)
New COVID-19 Vaccination Mandates Make Rapid COVID Tests More Essential Than Ever FinancialNewsMedia - Thu Aug 19, 7:50AM CDT

FN Media Group Presents Microsmallcap.com Market Commentary

SIXWF : 0.1953 (+3.01%)
SIXW.CN : 0.250 (+2.04%)
CODX : 8.35 (-0.95%)
COCP : 0.7150 (-6.30%)
MRK : 73.34 (-0.74%)
MRNA : 306.72 (+1.73%)

Barchart Exclusives

Corn: Long Live the King Barchart - Fri Dec 3, 4:51PM CST
Is King Corn still a buy? That is a question that came in Friday as markets in general were making big moves. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] CDT
Reserve Your Spot